MedPath

Vetter Pharma-Fertigung GmbH & Co. KG

Vetter Pharma-Fertigung GmbH & Co. KG logo
🇩🇪Germany
Ownership
Subsidiary
Established
1950-01-01
Employees
5K
Market Cap
-
Website
http://www.vetter-pharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

SFDA:15
PHILIPPINES:9
NMPA:6

Drug Approvals

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
J20171061
Approval Date
Sep 25, 2017
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字J20171061
Approval Date
Sep 25, 2017
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
J20171059
Approval Date
Sep 25, 2017
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字J20171059
Approval Date
Sep 25, 2017
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
J20171060
Approval Date
Sep 25, 2017
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字J20171060
Approval Date
Sep 25, 2017
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.